MX2023002027A - Cepas microbianas y antibioticos. - Google Patents

Cepas microbianas y antibioticos.

Info

Publication number
MX2023002027A
MX2023002027A MX2023002027A MX2023002027A MX2023002027A MX 2023002027 A MX2023002027 A MX 2023002027A MX 2023002027 A MX2023002027 A MX 2023002027A MX 2023002027 A MX2023002027 A MX 2023002027A MX 2023002027 A MX2023002027 A MX 2023002027A
Authority
MX
Mexico
Prior art keywords
antibiotics
strains
microbial strains
relates
tulathromycin
Prior art date
Application number
MX2023002027A
Other languages
English (en)
Inventor
Michael R King
Sona Son
Kyle Leistikow
Original Assignee
Microbial Discovery Group Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Discovery Group Llc filed Critical Microbial Discovery Group Llc
Publication of MX2023002027A publication Critical patent/MX2023002027A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a microbios de alimentación directa para su uso en la inhibición de E. coli en animales en combinación con antibióticos seleccionados del grupo que consiste de ceftiofur, oxitetraciclina, tulatromicina y lincomicina. Más particularmente, la invención se refiere a las cepas aisladas 2, 3, 4, 5, 9, 57, 71 y 126 de Bacillus, y a las cepas que tienen todas las características de identificación de estas cepas, para un uso que comprende el uso mencionado anteriormente.
MX2023002027A 2020-08-21 2021-08-18 Cepas microbianas y antibioticos. MX2023002027A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063068668P 2020-08-21 2020-08-21
PCT/US2021/046451 WO2022040279A1 (en) 2020-08-21 2021-08-18 Microbial strains and antibiotics

Publications (1)

Publication Number Publication Date
MX2023002027A true MX2023002027A (es) 2023-03-15

Family

ID=80350535

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023002027A MX2023002027A (es) 2020-08-21 2021-08-18 Cepas microbianas y antibioticos.

Country Status (7)

Country Link
US (1) US20230321162A1 (es)
EP (1) EP4199705A1 (es)
CN (1) CN116600644A (es)
BR (1) BR112023002974A2 (es)
CA (1) CA3192214A1 (es)
MX (1) MX2023002027A (es)
WO (1) WO2022040279A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618640B2 (en) * 2004-05-14 2009-11-17 Agtech Products, Inc. Method and composition for reducing E. coli disease and enhancing performance
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
KR102128560B1 (ko) * 2012-04-13 2020-07-01 시에이치알. 한센 에이/에스 대장균 및 클로스트리디움 퍼프린젠스에 대한 항균 효과 및 높은 포자 형성 능력을 갖는 항생제 민감성 바실러스 균주
MX2016014901A (es) * 2014-05-13 2017-06-29 Microbial Discovery Group Llc Composiciones microbianas para alimentacion directa y sus metodos de uso.
WO2017151608A1 (en) * 2016-02-29 2017-09-08 Microbial Discovery Group Llc Direct-fed microbials
CA3056482A1 (en) * 2017-03-14 2018-09-20 Chr. Hansen A/S Bacillus subtilis strains improving animal performance parameters
US11856970B2 (en) * 2018-01-19 2024-01-02 Chr. Hansen A/S Bacillus subtilis for animal feed
BR112020015756A2 (pt) * 2018-02-02 2020-12-15 Novozymes A/S Gestão de lawsonia patogênica
EP4017275A4 (en) * 2019-08-22 2023-10-04 Microbial Discovery Group, LLC INHIBITION PROCESSES WITH MICROBIAL STRAIN AND ANTIBIOTICS

Also Published As

Publication number Publication date
EP4199705A1 (en) 2023-06-28
US20230321162A1 (en) 2023-10-12
CN116600644A (zh) 2023-08-15
WO2022040279A1 (en) 2022-02-24
BR112023002974A2 (pt) 2023-04-04
CA3192214A1 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
WO2007136719A3 (en) Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
Clements et al. Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains
AU2002257966A1 (en) Immunostimulatory agent comprising a biomass of methanotrophic bacterium
MXPA03002683A (es) Cepas de escherichia coli las cuales sobreproducen l-treonina y procedimientos para produccion de l-treonina mediante fermentacion..
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
WO2019175783A8 (en) Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
Woo et al. Facilitation of horizontal transfer of antimicrobial resistance by transformation of antibiotic-induced cell-wall-deficient bacteria
MX2022002101A (es) Metodos de inhibicion con cepas microbianas y antibioticos.
MX2020011464A (es) Microbios para alimentacion.
TW200510541A (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
ES553227A0 (es) Un procedimiento para preparar derivados monoamidicos basicos de actagardina
MX2023002027A (es) Cepas microbianas y antibioticos.
KR101494230B1 (ko) 바실러스 아밀로리쿼파시엔스의 신규 변이주 및 이를 포함하는 동물사료 첨가제
Sen et al. Molecular characterization and in vitro analyses of a sporogenous bacterium with potential probiotic properties
MX2009006808A (es) Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico.
MX2023002033A (es) Microbios y antibioticos.
MX2023005934A (es) Cepa de bacillus subtilis con fuerte inhibicion de bacterias enteropatogenas y patogenas transmitidas por los alimentos.
Heshmatipour et al. Antibacterial activity lactic acid bacteria (LAB) isolated native yogurt against ESBL producing E. coli causing urinary tract infection (UTI)
KR101799837B1 (ko) 신규한 엔테로코커스 페칼리스 균주 및 이를 포함하는 프로바이오틱스
Gupta et al. Evaluation of antagonistic activities of Bacillus spp. against certain bacteria of medical importance
Mani et al. Molecular and functional characterization of metabolites from terrestrial Streptomyces hygroscopicus AVS7 isolated from Western Ghats, India
Al-hulu Antibacterial activity for Biosurfactant produced by streptomyces spp. isolated from soil samples
姜成英 et al. Isolation of soil bacteria species for degrading dibenzothiophene
Sabia et al. Interference of Lactobacillus plantarum strains in the in vitro conjugative transfer of R-plasmids
Yadav et al. Endophytic Streptomyces rochei BpR-2 GER (ON142045) from Bryophyllum pinnatum (Lam.) Oken with Antimicrobial and Antibiofilm Potential